335 related articles for article (PubMed ID: 19361981)
21. Genetic predisposition of E-selectin gene (S128R) polymorphism in patients with coronary artery disease (CAD).
Tripathi R; Singh PK; Tewari S; Tamhankar PM; Ramesh V; Agarwal S
Indian J Med Res; 2009 Oct; 130(4):423-7. PubMed ID: 19942746
[TBL] [Abstract][Full Text] [Related]
22. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
23. MANBA polymorphism was related to increased risk of colorectal cancer in Swedish but not in Chinese populations.
Gao J; Arbman G; He L; Qiao F; Zhang Z; Zhao Z; Rosell J; Sun XF
Acta Oncol; 2008; 47(3):372-8. PubMed ID: 17899454
[TBL] [Abstract][Full Text] [Related]
24. SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer.
Chang SC; Lin PC; Yang SH; Wang HS; Li AF; Lin JK
Ann Surg Oncol; 2009 Aug; 16(8):2323-30. PubMed ID: 19472013
[TBL] [Abstract][Full Text] [Related]
25. Improved survival in young women with colorectal cancer.
Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
[TBL] [Abstract][Full Text] [Related]
26. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
27. E-selectin genotypes and risk of type 2 diabetes in women.
Meigs JB; Hu FB; Perhanidis JS; Hunter D; Rifai N; Manson JE
Obes Res; 2005 Mar; 13(3):513-8. PubMed ID: 15833936
[TBL] [Abstract][Full Text] [Related]
28. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
Iglesias D; Nejda N; Azcoita MM; Schwartz S; González-Aguilera JJ; Fernández-Peralta AM
Cancer Causes Control; 2009 Oct; 20(8):1421-9. PubMed ID: 19468846
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD44v6 has no prognostic value in patients with colorectal cancer.
Jüngling B; Menges M; Goebel R; Wittig BM; Weg-Remers S; Pistorius G; Schilling M; Bauer M; König J; Zeitz M; Stallmach A
Z Gastroenterol; 2002 Apr; 40(4):229-33. PubMed ID: 11961731
[TBL] [Abstract][Full Text] [Related]
30. A multivariate analysis of prognostic determinants for stages II and III colorectal cancer in 141 patients.
Zhou ZG; Wu XJ; Li LR; Peng ZH; Ding PR; Wang RJ; Pan ZZ
Chin Med J (Engl); 2011 Jul; 124(14):2132-5. PubMed ID: 21933615
[TBL] [Abstract][Full Text] [Related]
31. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
[TBL] [Abstract][Full Text] [Related]
32. The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease.
Testa A; Benedetto FA; Spoto B; Pisano A; Tripepi G; Mallamaci F; Malatino LS; Zoccali C
Nephrol Dial Transplant; 2006 Jul; 21(7):1921-6. PubMed ID: 16554320
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis.
Watson MA; Gay L; Stebbings WS; Speakman CT; Bingham SA; Loktionov A
Clin Sci (Lond); 2003 May; 104(5):537-45. PubMed ID: 12529167
[TBL] [Abstract][Full Text] [Related]
34. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
[TBL] [Abstract][Full Text] [Related]
35. DNA image cytometry is a useful adjunct tool in the prediction of disease outcome in patients with stage II and stage III colorectal cancer.
Buhmeida A; Algars A; Ristamäki R; Collan Y; Syrjänen K; Pyrhönen S
Oncology; 2006; 70(6):427-37. PubMed ID: 17220640
[TBL] [Abstract][Full Text] [Related]
36. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer.
Rahbari NN; Aigner M; Thorlund K; Mollberg N; Motschall E; Jensen K; Diener MK; Büchler MW; Koch M; Weitz J
Gastroenterology; 2010 May; 138(5):1714-26. PubMed ID: 20100481
[TBL] [Abstract][Full Text] [Related]
39. Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay.
Douard R; Wind P; Sales JP; Landi B; Berger A; Benichou J; Gayral F; Loric S; Cugnenc PH
Surgery; 2006 Apr; 139(4):556-62. PubMed ID: 16627067
[TBL] [Abstract][Full Text] [Related]
40. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients.
Martínez-Fernandez A; García-Albeniz X; Pineda E; Visa L; Gallego R; Codony-Servat J; Augé JM; Longarón R; Gascón P; Lacy A; Castells A; Maurel J
Ann Surg Oncol; 2009 May; 16(5):1412-20. PubMed ID: 19259740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
